Financhill
Sell
14

QID Quote, Financials, Valuation and Earnings

Last price:
$19.52
Seasonality move :
-4.29%
Day range:
$19.52 - $19.68
52-week range:
$19.12 - $50.45
Dividend yield:
7.02%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
16.5M
Avg. volume:
25.2M
1-year change:
-35.64%
Market cap:
--
Revenue:
--
EPS (TTM):
--

QID Analysts' Consensus Rating

No consensus rating exists at this time due to lack of analyst coverage.

Consensus Price Target

--

Highest Price Target

--

Lowest Price Target

--

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Analyst Ratings

6M Ago 1M Ago Current
Buy 0 0 0

Hold 0 0 0

Sell 0 0 0
Consensus -- -- --

QID Recommendation Trends

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
85
HUT alert for Dec 25

Hut 8 Corp. [HUT] is up 0.65% over the past day.

Buy
80
TVTX alert for Dec 25

Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.

Buy
63
GPCR alert for Dec 25

Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock